Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Technology Services » Internet Software Or Services
|AFRM||Affirm Holdings, Inc.||-1.17%||146.73||0.0%||$2858.79m|
|UPST||Upstart Holdings, Inc.||2.72%||390.00||0.0%||$1987.41m|
|SE||Sea Ltd. (Singapore)||2.65%||354.51||3.1%||$1018.72m|
|MTCH||Match Group, Inc.||1.92%||160.02||4.3%||$846.29m|
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.